Adjuvant erlotinib increased overall survival when compared to chemotherapy in stage IIIA EGFR-mutant non-small cell lung cancer
1. Erlotinib showed an overall survival benefit and improved 5-year survival rates when compared...
Read MoreSep 6, 2022
1. Erlotinib showed an overall survival benefit and improved 5-year survival rates when compared...
Read MoreSep 6, 2022
1. Median progression-free survival was longer in the SG group than in the chemotherapy group. 2....
Read MoreSep 6, 2022
1. A higher physical function among community-dwelling older adults was associated with a...
Read MoreAug 27, 2022
1. In this randomized clinical trial, among 1893 patients with acute moderate ischemic stroke,...
Read MoreAug 27, 2022
1. Reinfection with hepatitis C virus (HCV) was highest in the first 24 weeks after treatment...
Read MoreAug 27, 2022
1. A self-monitoring blood pressure (SMBP) program enhanced with smartphone patient engagement...
Read MoreAug 27, 2022
1. Few studies included all concepts of the Body-Mind-Spirit (BMS), including detailed...
Read MoreAug 27, 2022
1. In a retrospective cohort of about 3,000 children and young adults, new diagnoses of type 2...
Read MoreAug 27, 2022
1. Two randomized clinical trials showed that intravenous ublituximab reduced relapse rate and the...
Read MoreAug 27, 2022
1. Olokizumab was superior to placebo in improving rheumatoid arthritis (RA) symptoms. 2....
Read MoreAug 27, 2022
1. In this longitudinal cohort study assessing the benefits of a cash supplementation program in...
Read MoreAug 27, 2022
1. Statin use in patients at increased risk of cardiovascular disease without prior history of...
Read MoreAug 24, 2022
1. There was a 27% reduction of severe asthma exacerbations in children treated with mepolizumab...
Read MoreAug 24, 2022
1. 80% of patients receiving mitapivat showed hemoglobin response at 12 weeks. 2. Markers of...
Read MoreAug 24, 2022
1. An improvement in cardiovascular disease (CVD) outcomes was found at 3 months and 6 months...
Read MoreAug 24, 2022
1. Patients on fazirsiran had reductions in total liver misfolded alpha1-antitrypsin protein...
Read MoreAug 23, 2022
1. Chronic kidney disease was independently associated with an increased risk of spontaneous...
Read MoreAug 23, 2022
1. Patients hospitalized due to COVID-19 had a higher risk of developing a venous thromboembolism...
Read MoreAug 21, 2022
1. This cross-sectional study using survey data from individuals in US states with high overdose...
Read MoreAug 19, 2022
1. In this retrospective study, newborn screening for cystic fibrosis in the United States lead...
Read More